These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9297604)

  • 1. Contact activation of plasmatic coagulation on polymeric membranes measured by the activity of kallikrein in heparinized plasma.
    Groth T; Synowitz J; Malsch G; Richau K; Albrecht W; Lange KP; Paul D
    J Biomater Sci Polym Ed; 1997; 8(10):797-807. PubMed ID: 9297604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution, and pH.
    Renaux JL; Thomas M; Crost T; Loughraieb N; Vantard G
    Kidney Int; 1999 Mar; 55(3):1097-103. PubMed ID: 10027949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials.
    van der Kamp KW; van Oeveren W
    J Biomed Mater Res; 1994 Mar; 28(3):349-52. PubMed ID: 7521336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A kallikrein-targeting RNA aptamer inhibits the intrinsic pathway of coagulation and reduces bradykinin release.
    Steen Burrell KA; Layzer J; Sullenger BA
    J Thromb Haemost; 2017 Sep; 15(9):1807-1817. PubMed ID: 28632925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro contact phase activation with haemodialysis membranes: role of pharmaceutical agents.
    Matata BM; Wark S; Sundaram S; Courtney JM; Gaylor JD; Bowry SK; Vienken J; Lowe GD
    Biomaterials; 1995 Nov; 16(17):1305-12. PubMed ID: 8573668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of the influence of biomaterials on contact activation.
    Sundaram S; Irvine L; Courtney JM; Lowe GD
    Int J Artif Organs; 1991 Nov; 14(11):729-31. PubMed ID: 1661710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro investigation of the blood response to medical grade PVC and the effect of heparin on the blood response.
    Lamba NM; Courtney JM; Gaylor JD; Lowe GD
    Biomaterials; 2000 Jan; 21(1):89-96. PubMed ID: 10619682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin generation by dialysis membranes: possible role in anaphylactic reaction.
    Schulman G; Hakim R; Arias R; Silverberg M; Kaplan AP; Arbeit L
    J Am Soc Nephrol; 1993 Mar; 3(9):1563-9. PubMed ID: 8507811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of plasma kallikrein. Kininase and kinin-like activities of preparations from the medicinal leeches.
    Baskova IP; Khalil S; Nartikova VF; Paskhina TS
    Thromb Res; 1992 Sep; 67(6):721-30. PubMed ID: 1440537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of blood biocompatibility during haemodialysis with cuprophane and polyacrylonitrile membranes.
    Seyfert UT; Helmling E; Hauck W; Skroch D; Albert W
    Nephrol Dial Transplant; 1991; 6(6):428-34. PubMed ID: 1876284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of heparinized Cuprophan hemodialysis membranes.
    Hinrichs WL; ten Hoopen HW; Engbers GH; Feijen J
    J Biomed Mater Res; 1997 Jun; 35(4):443-50. PubMed ID: 9189822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic ultrasound activates pure prekallikrein.
    Stief TW; Klingmüller V
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):781-3. PubMed ID: 22964768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation.
    Wachtfogel YT; Hack CE; Nuijens JH; Kettner C; Reilly TM; Knabb RM; Bischoff R; Tschesche H; Wenzel H; Kucich U
    Am J Physiol; 1995 Mar; 268(3 Pt 2):H1352-7. PubMed ID: 7535008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of blood coagulation, fibrinolytic and kallikrein systems during storage of plasma.
    Blombäck M; Chmielewska J; Netré C; Akerblom O
    Vox Sang; 1984; 47(5):335-42. PubMed ID: 6209855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
    Olson ST; Sheffer R; Francis AM
    Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.
    El Moujahed A; Brillard-Bourdet M; Juliano MA; Moreau T; Chagas JR; Gutman N; Prado ES; Gauthier F
    Eur J Biochem; 1997 Jul; 247(2):652-8. PubMed ID: 9266709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma recalcification as a measure of contact phase activation and heparinization efficacy after contact with biomaterials.
    Rhodes NP; Williams DF
    Biomaterials; 1994 Jan; 15(1):35-7. PubMed ID: 8161655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of blood purification materials and anticoagulants on the contact activity of factor XI].
    Cheng LP; Sun SD; Yue YL; Huang J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):411-4. PubMed ID: 15931883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Centrifugal analysis for plasma kallikrein activity, with use of the chromogenic substrate S-2302.
    Ito R; Statland BE
    Clin Chem; 1981 Apr; 27(4):586-93. PubMed ID: 6907061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.